Generation of a human induced pluripotent stem cell line (CRICKi021-A) from a patient with Ullrich congenital muscular dystrophy carrying a pathogenic mutation in the COL6A1 gene

More about Open Access at the Crick

Authors list

Yunsong Jiang Liani Devito Francesco Muntoni Lyn Healy Francesco Saverio Tedesco
Scroll for detail on labs, facilities & authors

Abstract

Ullrich congenital muscular dystrophy (UCMD) represents the most severe subtype of collagen VI-related dystrophies (COL6-RDs), a spectrum of rare extracellular matrix disorders affecting skeletal muscle and connective tissue. Here, we generated an induced pluripotent stem cell (iPSC) line (CRICKi021-A) from a UCMD patient with de novo dominant-negative mutation in COL6A1 gene by reprogramming dermal fibroblasts using a non-integrating mRNA-based protocol. The resulting human iPSCs displayed normal morphology, expressed pluripotency-associated markers and differentiated into the three germ layers. This new COL6A1-mutant iPSC line can be employed for disease modelling and for investigating potential therapies for COL6-RDs.

Journal details

Journal Stem Cell Research
Volume 83
Pages 103648
Available online
Publication date

Full text links

Publisher website (DOI) 10.1016/j.scr.2024.103648
Download Download full text [pdf]
Europe PubMed Central 39764974
Pubmed 39764974

Keywords

Related topics
Type of publication